Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Principle Study of Atomoxetine for the Prevention of Vasovagal Syncope (VVS): POST6

NCT02500732 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT02500732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02500732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Principle Study of Atomoxetine for the Prevention of Vasovagal Syncope (VVS): POST6
Lead sponsor
University of Calgary
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2015
Completion date
March 31, 2018
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vasovagal syncope